1. Home
  2. FN vs ARWR Comparison

FN vs ARWR Comparison

Compare FN & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fabrinet

FN

Fabrinet

SELL

Current Price

$455.21

Market Cap

14.6B

Sector

Utilities

ML Signal

SELL

Logo Arrowhead Pharmaceuticals Inc.

ARWR

Arrowhead Pharmaceuticals Inc.

SELL

Current Price

$60.65

Market Cap

12.4B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
FN
ARWR
Founded
1999
2003
Country
Cayman Islands
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.6B
12.4B
IPO Year
2007
2009

Fundamental Metrics

Financial Performance
Metric
FN
ARWR
Price
$455.21
$60.65
Analyst Decision
Buy
Strong Buy
Analyst Count
9
14
Target Price
★ $734.11
$107.23
AVG Volume (30 Days)
779.7K
★ 2.1M
Earning Date
11-02-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
42.31
★ 99.80
EPS
★ 13.05
N/A
Revenue
★ $4,641,097,000.00
$16,142,321.00
Revenue This Year
$31.50
N/A
Revenue Next Year
$19.73
N/A
P/E Ratio
$37.33
★ N/A
Revenue Growth
★ 35.73
N/A
52 Week Low
$366.49
$34.61
52 Week High
$748.89
$95.49

Technical Indicators

Market Signals
Indicator
FN
ARWR
Relative Strength Index (RSI) 52.76 29.60
Support Level $449.04 $54.02
Resistance Level $501.69 $66.37
Average True Range (ATR) 22.67 2.27
MACD 8.04 0.08
Stochastic Oscillator 51.11 10.95

Price Performance

Historical Comparison
FN
ARWR

About FN Fabrinet

Fabrinet provides advance-level optical packaging and precision optical, electro-mechanical, and electronic manufacturing services to original equipment manufacturers of complex products, such as optical communication components, modules and sub-systems, industrial lasers, automotive components, medical devices, and sensors. The company offers a broad range of advance optical and electro-mechanical capabilities across the entire manufacturing process, including process design and engineering, supply chain management, manufacturing, complex printed circuit board assembly, advance-level of packaging, integration, final assembly, and testing. The company generates the majority of its revenue from North America and Asia-Pacific, with the rest from Europe.

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.

Share on Social Networks: